A recent immunohistochemistry-based study demonstrated that CIP2A signature clustered with basal-type and HER2-positive breast cancer signatures and suggested that CIP2A is linked to these two subtypes of breast cancer [36]. Here, CIP2A is linked to breast carcinoma.